American journal of surgery最新文献

英文中文

A chasm is growing between clinical care and education: Who will train the next surgeons? 临床护理和教育之间的鸿沟正在扩大：谁来培训下一批外科医生？

IF 2.7 3区医学 Q1 SURGERY

American journal of surgery

Pub Date : 2026-01-09 DOI: 10.1016/j.amjsurg.2026.116822

Kevin Y Pei

引用次数: 0

The unseen complication: Relationship strain in surgical practice. 看不见的并发症：手术实践中的关系紧张。

IF 2.7 3区医学 Q1 SURGERY

American journal of surgery

Pub Date : 2026-01-07 DOI: 10.1016/j.amjsurg.2026.116820

Amanda L Smith, Kathryn E Engelhardt

引用次数: 0

Emeritus Editorial Board 名誉编辑委员会

IF 2.7 3区医学 Q1 SURGERY

American journal of surgery

Pub Date : 2026-01-07 DOI: 10.1016/S0002-9610(25)00630-0

引用次数: 0

The general surgery match in the step 1 pass/fail era: Leveling the playing field or moving the goalpost? 第一步及格/不及格时代的普外科比赛：公平竞争还是移动门柱？

IF 2.7 3区医学 Q1 SURGERY

American journal of surgery

Pub Date : 2026-01-05 DOI: 10.1016/j.amjsurg.2026.116818

Carla N Holcomb, Thomas H Shoultz

引用次数: 0

Statewide episode spending variation of thyroidectomy for lower-risk thyroid cancer 低风险甲状腺癌甲状腺切除术的全州发作花费变化

IF 2.7 3区医学 Q1 SURGERY

American journal of surgery

Pub Date : 2025-12-31 DOI: 10.1016/j.amjsurg.2025.116816

Catherine B. Jensen , Steven Xie , Aayushi Sinha , Elizabeth M. Bacon , Hunter J. Underwood , Hari Nathan , Susan C. Pitt

Background

This study aimed to evaluate variation in spending for thyroidectomy for patients with thyroid cancer.

Methods

This retrospective cohort study analyzed risk-adjusted, price-standardized Michigan-based claims data from 2015 to 2022 and included patients who underwent thyroidectomy for lower-risk thyroid cancer. The primary outcome was 90-day spending. A mixed linear model with facility as a random effect identified factors associated with spending variability.

Results

In total, 2516 patients underwent thyroidectomy at 81 facilities. Unadjusted 90-day spending ranged from $5917 to $25,630 across facilities (median $8993). Spending was lowest for lobectomy (median $7755) and highest for lobectomy followed by completion thyroidectomy (median $14,181). On regression, factors significantly associated with increased spending were patient age and readmission. The interaction between occurrence of post-operative complications and lengths of stay >2 nights contributed to dramatically higher spending.

Conclusions

Reducing complications and associated length of stay as well hospital readmissions represent opportunities to improve the value of thyroidectomy.

本研究旨在评估甲状腺癌患者甲状腺切除术费用的变化。方法：本回顾性队列研究分析了2015年至2022年风险调整、价格标准化的密歇根州索赔数据，其中包括因低风险甲状腺癌接受甲状腺切除术的患者。主要结果是90天的支出。将设施作为随机效应的混合线性模型确定了与支出可变性相关的因素。结果81家医院共2516例患者行甲状腺切除术。未经调整的90天支出从5917美元到25,630美元不等（中位数为8993美元）。肺叶切除术的费用最低（中位数为7755美元），肺叶切除术后完成甲状腺切除术的费用最高（中位数为14181美元）。在回归分析中，与支出增加显著相关的因素是患者年龄和再入院率。术后并发症的发生与住院时间（2晚）之间的相互作用导致了住院费用的显著增加。结论减少并发症和相关住院时间以及再入院率是提高甲状腺切除术价值的机会。

{"title":"Statewide episode spending variation of thyroidectomy for lower-risk thyroid cancer","authors":"Catherine B. Jensen , Steven Xie , Aayushi Sinha , Elizabeth M. Bacon , Hunter J. Underwood , Hari Nathan , Susan C. Pitt","doi":"10.1016/j.amjsurg.2025.116816","DOIUrl":"10.1016/j.amjsurg.2025.116816","url":null,"abstract":"<div><h3>Background</h3><div>This study aimed to evaluate variation in spending for thyroidectomy for patients with thyroid cancer.</div></div><div><h3>Methods</h3><div>This retrospective cohort study analyzed risk-adjusted, price-standardized Michigan-based claims data from 2015 to 2022 and included patients who underwent thyroidectomy for lower-risk thyroid cancer. The primary outcome was 90-day spending. A mixed linear model with facility as a random effect identified factors associated with spending variability.</div></div><div><h3>Results</h3><div>In total, 2516 patients underwent thyroidectomy at 81 facilities. Unadjusted 90-day spending ranged from $5917 to $25,630 across facilities (median $8993). Spending was lowest for lobectomy (median $7755) and highest for lobectomy followed by completion thyroidectomy (median $14,181). On regression, factors significantly associated with increased spending were patient age and readmission. The interaction between occurrence of post-operative complications and lengths of stay >2 nights contributed to dramatically higher spending.</div></div><div><h3>Conclusions</h3><div>Reducing complications and associated length of stay as well hospital readmissions represent opportunities to improve the value of thyroidectomy.</div></div>","PeriodicalId":7771,"journal":{"name":"American journal of surgery","volume":"253 ","pages":"Article 116816"},"PeriodicalIF":2.7,"publicationDate":"2025-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145973553","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The proverbial glass ceiling: You might need a new tool when it's seemingly made of concrete 众所周知的玻璃天花板：你可能需要一个新的工具，当它看起来是由混凝土制成的。

IF 2.7 3区医学 Q1 SURGERY

American journal of surgery

Pub Date : 2025-12-30 DOI: 10.1016/j.amjsurg.2025.116814

Alana L. Beres MDCM, MPH, FRCSC, FACS, FAAP

引用次数: 0

Statewide trends in routine pre-operative testing before low-risk surgery 低风险手术前常规术前检查的全州趋势

IF 2.7 3区医学 Q1 SURGERY

American journal of surgery

Pub Date : 2025-12-29 DOI: 10.1016/j.amjsurg.2025.116815

Nicole M. Mott , Erin Kim , Faelan Jacobson-Davies , Michael J. Englesbe , Hari Nathan , Lesly A. Dossett

Background

Routine pre-operative testing before low-risk surgery remains common despite guidelines against it.

Methods

We conducted a retrospective cohort study of adults undergoing low-risk surgery (cholecystectomy, hernia repair, lumpectomy, thyroidectomy, mastectomy) in Michigan from 2015 to 2024. The primary outcome was testing performed within 30 days of surgery. Linear mixed models identified predictors of testing, and the results of a pilot quality improvement (QI) initiative to reduce testing at 31 hospitals were examined.

Results

Among 99,501 patients, testing rates declined from 44 % to 39 % from 2019 to 2024. Older age, comorbidity burden, and undergoing a pre-operative history and physical were associated with testing. Hospital testing rates varied from 13 % to 93 %. In the QI-participating hospitals, testing declined from 38 % to 33 % in the measurement period compared to the baseline period (p = 0.035).

Conclusions

Pre-operative testing remains common and variable. QI initiatives help reduce testing, but broader de-implementation strategies may promote sustained improvement.

背景：尽管指南反对在低风险手术前进行常规术前检查，但这种做法仍然很普遍。方法对2015年至2024年在密歇根州接受低风险手术（胆囊切除术、疝修补术、乳房肿瘤切除术、甲状腺切除术、乳房切除术）的成年人进行回顾性队列研究。主要结果是手术后30天内进行的测试。线性混合模型确定了检测的预测因素，并检查了31家医院减少检测的试点质量改进（QI）倡议的结果。结果在99501例患者中，检测率从2019年的44%下降到2024年的39%。年龄较大、合并症负担、术前病史和体格检查与检测有关。医院检测率从13%到93%不等。在参与qi的医院中，与基线期相比，检测率从38%下降到33% （p = 0.035）。结论术前检测普遍存在，且存在差异。QI计划有助于减少测试，但是更广泛的去实现策略可能促进持续的改进。

{"title":"Statewide trends in routine pre-operative testing before low-risk surgery","authors":"Nicole M. Mott , Erin Kim , Faelan Jacobson-Davies , Michael J. Englesbe , Hari Nathan , Lesly A. Dossett","doi":"10.1016/j.amjsurg.2025.116815","DOIUrl":"10.1016/j.amjsurg.2025.116815","url":null,"abstract":"<div><h3>Background</h3><div>Routine pre-operative testing before low-risk surgery remains common despite guidelines against it.</div></div><div><h3>Methods</h3><div>We conducted a retrospective cohort study of adults undergoing low-risk surgery (cholecystectomy, hernia repair, lumpectomy, thyroidectomy, mastectomy) in Michigan from 2015 to 2024. The primary outcome was testing performed within 30 days of surgery. Linear mixed models identified predictors of testing, and the results of a pilot quality improvement (QI) initiative to reduce testing at 31 hospitals were examined.</div></div><div><h3>Results</h3><div>Among 99,501 patients, testing rates declined from 44 % to 39 % from 2019 to 2024. Older age, comorbidity burden, and undergoing a pre-operative history and physical were associated with testing. Hospital testing rates varied from 13 % to 93 %. In the QI-participating hospitals, testing declined from 38 % to 33 % in the measurement period compared to the baseline period (p = 0.035).</div></div><div><h3>Conclusions</h3><div>Pre-operative testing remains common and variable. QI initiatives help reduce testing, but broader de-implementation strategies may promote sustained improvement.</div></div>","PeriodicalId":7771,"journal":{"name":"American journal of surgery","volume":"253 ","pages":"Article 116815"},"PeriodicalIF":2.7,"publicationDate":"2025-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145922119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Can Artificial Intelligence and Machine Learning help us improve motor vehicle crash trauma triage? 人工智能和机器学习能帮助我们改善机动车碰撞创伤分诊吗？

IF 2.7 3区医学 Q1 SURGERY

American journal of surgery

Pub Date : 2025-12-26 DOI: 10.1016/j.amjsurg.2025.116810

Raymond A Jean, Akbar K Waljee, Maggie Makar, Christopher J Tignanelli, Mark R Hemmila, Justin B Dimick

引用次数: 0

The case for structural reform in medical student research access. 医学生研究机会结构改革的案例。

IF 2.7 3区医学 Q1 SURGERY

American journal of surgery

Pub Date : 2025-12-26 DOI: 10.1016/j.amjsurg.2025.116811

Tamara Kabbani, Anthony N Eze, Jacob A Greenberg, Lisa McElroy

引用次数: 0

Investigating racial/ethnic disparities in opioid use among patients undergoing gastrointestinal cancer surgery 调查胃肠癌手术患者阿片类药物使用的种族差异。

IF 2.7 3区医学 Q1 SURGERY

American journal of surgery

Pub Date : 2025-12-26 DOI: 10.1016/j.amjsurg.2025.116799

Shahzaib Zindani , Zayed Rashid , Selamawit Woldesenbet , Mujtaba Khalil , Timothy M. Pawlik

Introduction

We sought to investigate racial/ethnic disparities in opioid prescribing patterns among patients undergoing gastrointestinal (GI) cancer surgery.

Methods

Patients who underwent surgery for GI cancer (2016–2023) were identified using the EPIC Cosmos database. Multivariate analyses were conducted to assess differences in opioid prescription patterns postoperatively.

Results

168,220 individuals underwent GI cancer surgery (esophagus: 2.5 %; stomach: 4.1 %, pancreas: 9.7 %; hepatobiliary: 6.4 %; colorectal: 77.3 %); 52.9 % were male, 86.0 % were White with median age of 72 years (IQR: 62–80). Black patients were younger (68 years [IQR: 60–76] vs. 72 years [IQR: 63–81]) and had a lower Charlson Comorbidity Index score (>2) (66.2 % vs. 68.5 %) compared with White patients (both p < 0.001). On multivariable analysis, Black patients had similar odds of receiving opioids as White patients (OR: 1.01, 95 % CI: 0.95–1.08).

Conclusion

No race-based differences were noted in the use of opioid prescriptions, duration of prescriptions, or mode of opioid administration following GI surgery.

前言：我们试图调查在接受胃肠道（GI）癌症手术的患者中阿片类药物处方模式的种族/民族差异。方法：使用EPIC Cosmos数据库对2016-2023年接受GI癌手术的患者进行识别。进行多变量分析以评估术后阿片类药物处方模式的差异。结果：168,220例患者接受了胃肠道肿瘤手术（食道2.5%，胃4.1%，胰腺9.7%，肝胆6.4%，结直肠77.3%）；52.9%为男性，86.0%为白人，中位年龄72岁（IQR: 62 ~ 80）。黑人患者较白人患者年轻（68岁[IQR: 60-76]对72岁[IQR: 63-81]）， Charlson合并症指数评分（>2）较白人患者低（66.2%对68.5%）（p均< 0.001）。在多变量分析中，黑人患者与白人患者接受阿片类药物的几率相似（OR: 1.01, 95% CI: 0.95-1.08）。结论：在胃肠道手术后阿片类药物处方的使用、处方持续时间或阿片类药物给药方式方面没有种族差异。

{"title":"Investigating racial/ethnic disparities in opioid use among patients undergoing gastrointestinal cancer surgery","authors":"Shahzaib Zindani , Zayed Rashid , Selamawit Woldesenbet , Mujtaba Khalil , Timothy M. Pawlik","doi":"10.1016/j.amjsurg.2025.116799","DOIUrl":"10.1016/j.amjsurg.2025.116799","url":null,"abstract":"<div><h3>Introduction</h3><div>We sought to investigate racial/ethnic disparities in opioid prescribing patterns among patients undergoing gastrointestinal (GI) cancer surgery.</div></div><div><h3>Methods</h3><div>Patients who underwent surgery for GI cancer (2016–2023) were identified using the EPIC Cosmos database. Multivariate analyses were conducted to assess differences in opioid prescription patterns postoperatively.</div></div><div><h3>Results</h3><div>168,220 individuals underwent GI cancer surgery (esophagus: 2.5 %; stomach: 4.1 %, pancreas: 9.7 %; hepatobiliary: 6.4 %; colorectal: 77.3 %); 52.9 % were male, 86.0 % were White with median age of 72 years (IQR: 62–80). Black patients were younger (68 years [IQR: 60–76] vs. 72 years [IQR: 63–81]) and had a lower Charlson Comorbidity Index score (>2) (66.2 % vs. 68.5 %) compared with White patients (both p < 0.001). On multivariable analysis, Black patients had similar odds of receiving opioids as White patients (OR: 1.01, 95 % CI: 0.95–1.08).</div></div><div><h3>Conclusion</h3><div>No race-based differences were noted in the use of opioid prescriptions, duration of prescriptions, or mode of opioid administration following GI surgery.</div></div>","PeriodicalId":7771,"journal":{"name":"American journal of surgery","volume":"253 ","pages":"Article 116799"},"PeriodicalIF":2.7,"publicationDate":"2025-12-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145916607","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

首页上一页

下一页尾页

类型

全部化学•材料生命科学医学物理工程技术环境•农林材料科学地球科学法学管理学化学环境科学与生态学计算机科学教育学经济学农林科学人文科学生物学数学物理与天体物理心理学综合性期刊其他工业工程理学历史学农学文学信息工程

数据库

全部 ACS Publications Elsevier ieeexplore Springer The Royal Society of Chemistry Wiley

期刊

American journal of surgery

全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.

﹀